The gut microbiome in human neurological disease: A review

Abstract

Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high-throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multidisciplinary field are summarized to empower and engage the neurology community in this "newly discovered organ." Ann Neurol 2017;81:369-382.

Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014

“…This so-called ‘gut-brain axis’ is believed to link functions of the brain with peripheral intestinal functions 2. Especially, unbalances in the intestinal microbiome in relation to neurological diseases have recently taken the spotlight, with studies relating PD with a more proinflammatory gut milieu 21. Recent evidence for the gut as an initial site of PD pathology comes from a study by Sampson et al demonstrating the importance of the gut microbiota to the pathophysiology of neuroinflammation in the development of motor deficits in the α-syn-overexpressing mouse 22.…”

Aging and Alzheimer’s disease: Comparison and associations from molecular to system level

“…An early study found that subgingival microbiome is associated with changes in cognitive function (Cockburn et al, 2012). Please refer to Pistollato et al (2016) and Tremlett, Bauer, Appel‐Cresswell, Finlay, and Waubant (2017) as a starting point.…”

Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases

“…Increased gut permeability may enable microbes or microbial metabolites to enter the bloodstream (reviewed in Tremlett et al [16]). Further, gut microbes produce neuromodulating metabolites (e.g., short chain fatty acids) and can induce the production of neurotransmitters such as serotonin and neuromodulating hormones such as peptide YY.…”